Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer
NCT ID: NCT04967209
Last Updated: 2023-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-07-05
2021-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
NCT05011721
Utility of a Mobile Application for Young Women With Breast Cancer
NCT07009093
Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery
NCT04616300
Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software
NCT04980989
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
NCT00900367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years and older
* Female
* \> 6 months postpartum
* Not currently pregnant or planning to become pregnant in the next 5 months
* Diagnosed with stage I-IV breast cancer \< 5 years ago:
* Completed active breast cancer treatment (e.g., chemotherapy, radiation, surgery) 1 month to 5 years ago, with the exception of hormonal/endocrine therapy
* Currently prescribed hormone therapy (e.g. Tamoxifen) as a breast cancer treatment
* Not diagnosed with an eating disorder
* Healthy weight, overweight, or obesity (BMI ≥ 18.5)
* Willingness to use the program over the course of the 4 weeks in order to enable them to provide feedback on its features
* Own a smartphone with iOS operating system (i.e., Apple iPhone)
Exclusion Criteria
* Underweight (BMI \< 18.5)
* Currently pregnant or \<6 months postpartum
* Presence of a diagnosed physical or mental health condition or abnormality that impacts the ability to participate in a program that involves asking participants to monitor diet, physical activity, or weight (e.g., eating disorder, bipolar disorder). If there is any doubt at initial screening the investigator will recommend that the patient receives sign off from their clinical team.
* Currently undergoing IV chemotherapy or radiation
* Plans for surgery in the next 6 weeks
* Currently diagnosed or being treated for a second primary cancer (i.e. cancer of another organ, not due to breast cancer metastasis), with the exception of non-melanoma skin cancers (e.g. basal cell carcinoma)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Noom Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Noom, Inc
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00055029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.